Immune checkpoint inhibition an ‘important new frontier’ in lymphoma
Tuesday, December 22, 2015
John P. Leonard, M.D., a co-chair of Lymphoma & Myeloma 2015, reacts to two presentations that focused on the role of immunotherapy — specifically immune checkpoint inhibitors ― in the treatment of lymphoma in this video from Healio.com/Hem Onc Today.
“This is very exciting and it is an important new frontier, just as it is in solid tumors,” Leonard said.